EphB2 antibody

GeneTex

EphB2 antibody

9

WB: 1:1000. IHC-P: 1:10-1:50. FACS: 1:10-1:50. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Flow Cytometry, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

Unconjugated

EPHB2

EPH receptor B2

BDPLT22, CAPB, DRT, EK5, EPHT3, ERK, Hek5, PCBC, Tyro5, ephrin type-B receptor 2, EPH-like kinase 5, developmentally-regulated Eph-related tyrosine kinase, elk-related tyrosine kinase, eph tyrosine kinase 3, protein-tyrosine kinase HEK5, renal carcinoma antigen NY-REN-47, tyrosine-protein kinase TYRO5, tyrosine-protein kinase receptor EPH-3

Rabbit

IgG

Ephrin type-B receptor 2

This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]

Human

-20°C or -80°C,2°C to 8°C

12352203